{
}
UBS has maintained a 'Buy' rating for Sanofi, setting a target price of 110 euros ahead of the company's quarterly results due on October 25. Analyst Jo Walton highlighted the importance of the ongoing success of Dupixent and the market acceptance of Beyfortus.
Sanofi is investing 300 million euros for a 16% stake in a new joint venture with Orano Med to develop radiopharmaceuticals targeting rare cancers, particularly using the radioisotope lead-212. This partnership aims to leverage expertise in biopharma and nuclear technology to advance cancer treatment. The joint venture is valued at 1.9 billion euros, following Sanofi's recent licensing of an experimental drug for neuroendocrine tumors.
UBS has maintained a 'Buy' rating for Sanofi, setting a target price of 110 euros ahead of the company's quarterly results due on October 25. Analyst Jo Walton emphasized the importance of assessing the sustainability of Dupixent's success and the market acceptance of Beyfortus.
UBS has maintained a "Buy" rating for Sanofi, setting a target price of 110 euros ahead of the quarterly results due on October 25. Analyst Jo Walton will focus on the sustainability of Dupixent's success and the market acceptance of Beyfortus.
GITEX GLOBAL's DIGI_HEALTH 5.0 in Dubai showcased transformative digital health innovations, including AI-driven solutions and smart contact lenses, highlighting the UAE's commitment to advancing its digital health ecosystem. Industry leaders discussed AI's role in enhancing patient care, with significant advancements in robotics, genomics, and remote monitoring technologies. The event also announced plans for a future expo-summit in Thailand, aimed at addressing the growing demands of the digital health industry in Asia.
Argus has issued "buy" ratings for several pharmaceutical stocks, including Sanofi (SNY) with a $60 price target, Gilead Sciences (GILD) at $85, and GSK at $45. The sector is projected to grow significantly, driven by oncology sales, with companies like Johnson & Johnson and Merck also highlighted for their strong pipelines and dividend yields.
GSK announced positive results from two Phase 3 trials of its antibody drug depemokimab for chronic rhinosinusitis with nasal polyps (CRSwNP), showing significant suppression of nasal polyp growth and improved nasal obstruction compared to placebo. The drug, which targets IL-5, is also being studied for asthma and other inflammatory diseases, with potential peak annual sales exceeding £3 billion if approved. Detailed trial results will be presented at an upcoming scientific congress.
The FDA has approved Pfizer's Hympavzi for treating hemophilia A and B in patients aged 12 and older without inhibitors. This weekly injection reduces the activity of tissue factor pathway inhibitor, enhancing blood clotting. Hympavzi offers a new treatment option alongside gene therapies and other factor replacement drugs, showing superior results in lowering bleeding rates.
European countries and foundations have pledged nearly USD 700 million and reaffirmed commitments of USD 300 million to the WHO, emphasizing the need for sustainable funding to enhance global health initiatives. Key figures, including German Chancellor Olaf Scholz, announced significant contributions during the World Health Summit in Berlin, aiming to support WHO's investment cycle and its mission to improve health worldwide. The event highlighted the urgency of mobilizing resources ahead of the G20 Leaders' Summit next month.
Sanofi is in negotiations with private equity firm Clayton Dubilier & Rice to sell a 50% controlling stake in its consumer health business, Opella, potentially valued at around €15 billion ($16.4 billion). This sale would allow Sanofi to focus more on its biopharmaceutical operations, which generated over €18 billion in sales in the first half of the year. Opella, known for products like Allegra and Icy Hot, operates in 100 countries and employs over 11,000 people.
Sanofi
Companies
| Symbol | SNY |
| Name | Sanofi |
| Currency | USD |
| Sector | Health Care |
| IndustryGroup | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Pharmaceuticals |
| Market | NASDAQ Global Select |
| Country | France |
| State | |
| City | Paris |
| Zipcode | 75008 |
| Website | http://www.sanofi.com |
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
ubs maintains buy rating for sanofi with target price of 110 euros
13:31 17.10.2024
Sanofi invests 300 million euros in joint venture for radiopharmaceuticals
Euro
Eli Lilly and Company
Orano Group
Bristol-Myers Squibb Company
Novartis AG
AstraZeneca PLC
Bayer AG
Sanofi
FRA
USA
Paul Hudson
Bayer
AstraZeneca
Eli Lilly
Novartis
Show more
13:20 17.10.2024
ubs maintains buy rating for sanofi with target price of 110 euros
12:43 17.10.2024
ubs maintains buy rating for sanofi ahead of quarterly results
12:43 17.10.2024
groundbreaking digital health innovations showcased at gitex global in dubai
United States Dollar
Microsoft Corporation
Samsung
Lenovo
Hoffmann-La Roche AG
Sanofi
THA
ARE
DEU
KOR
Denis Ledenkof
Aneesh Singhal
Xpanceo
Alex Aliper
Jong-Soo Choi
Show more
09:57 17.10.2024
pharmaceutical stocks to consider for income and growth potential
Johnson & Johnson
Merck & Co., Inc.
Perrigo Company plc
GSK plc
Sanofi
Amgen Inc.
Gilead Sciences, Inc.
FRA
USA
Jasper Hellweg
Kristina Ruggeri
David Toung
Show more
20:44 15.10.2024
GSK reports positive Phase 3 results for chronic nasal condition drug
British Pound Sterling
Sanofi
Regeneron Pharmaceuticals, Inc.
Glaxosmithkline Export Ltd.
GBR
USA
Kaivan Khavandi
Show more
14:01 14.10.2024
Pfizer's Hympavzi receives FDA approval for hemophilia treatment options
United States Dollar
Pfizer Inc.
CSL Behring
BioMarin Pharmaceutical Inc.
Hoffmann-La Roche AG
Sanofi
USA
Starboard Value
Aamir Malik
Show more
13:45 14.10.2024
global leaders pledge nearly 700 million USD to support world health organization
United States Dollar
Euro
Sanofi
Novo Nordisk A/S
Boehringer Ingelheim KG
GRC
FRA
NLD
ESP
DEU
FIN
IRL
DNK
MRT
MLT
MNE
EST
NOR
GBR
LUX
Kristen Michal
Ursula von der Leyen
Milojko Spajić
Olaf Scholz
Jonas Gahr Støre
Show more
09:00 14.10.2024
sanofi in talks to sell consumer health business to private equity firm
Euro
United States Dollar
Clayton, Dubilier & Rice LLC
McKesson Corporation
Glaxosmithkline Export Ltd.
Pfizer Inc.
Merck & Co., Inc.
Novartis AG
Sanofi
Johnson & Johnson
FRA
USA
François Roger
Merck & Co.
Show more
13:47 11.10.2024
Trending
Subcategory
Industry Trends
Corporate News
Global Trade Developments
Government Economic Policies
Supply Chain Management
Startups & Entrepreneurship
Retail and Consumer Goods
Energy Sector Developments
Cryptocurrency & Blockchain Regulations
Emerging Startups
Funding Rounds & Investments
Industry Mergers & Acquisitions
Banking & Investment Regulations
Stock Market Updates
Anti-Money Laundering (AML) Regulations
Tax Policy & Corporate Taxation
CEO Changes
Foreign Exchange Rates
Financial Scams and Security
Finance Mergers & Acquisitions
Countries:
Companies:
Apple Inc.
Learning Resources Inc.
MGA Entertainment Inc.
State Street Global Advisors Luxembourg SICAV - SSGA EMU ESG Screened Equity Fund
European Union Bonds
SLB 4,6% 01JUN25
Equinor Ventures AS
Quanta Services, Inc.
Gold Circuit Electronics Ltd.
Unimicron Technology Corp.
Yatra Online, Inc.
Daiwa Institute OF Research Ltd.
Pegatron Corporation
KODEX India Tata Group
Wistron Corporation
Foxconn Technology Co., Ltd.
Volkswagen AG
XIAOMI-W
XPeng Inc.
Tesla, Inc.
Currencies:
United States Dollar
Chinese Yuan
Indian Rupee
United Arab Emirates Dirham
Japanese Yen
Vietnamese Đồng
New Taiwan Dollar
Euro
Australian Dollar
Thai Baht
Saudi Riyal
People: